The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial

Hiroki Shiomi, Takeshi Morimoto, Shoji Kitaguchi, Yoshihisa Nakagawa, Katsuhisa Ishii, Yoshisumi Haruna, Itaru Takamisawa, Makoto Motooka, Kazuhiro Nakao, Shintaro Matsuda, Satoru Mimoto, Yutaka Aoyama, Teruki Takeda, Koichiro Murata, Masaharu Akao, Tsukasa Inada, Hiroshi Eizawa, Eiji Hyakuna, Kojiro Awano, Manabu ShirotaniYutaka Furukawa, Kazushige Kadota, Katsumi Miyauchi, Masaru Tanaka, Yuichi Noguchi, Sunao Nakamura, Satoshi Yasuda, Shunichi Miyazaki, Hiroyuki Daida, Kazuo Kimura, Yuji Ikari, Haruo Hirayama, Tetsuya Sumiyoshi, Takeshi Kimura, Kazuo Kimura, Kiyoshi Hibi, Kazuaki Kataoka, Shunichi Miyazaki, Satoshi Yasuda, Mitsuru Ishii, Eiji Momona, Sunao Nakamura, Akinori Takizawa, Mamoru Nanasato

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Abstract

Objectives The purpose of this study was to evaluate long-term clinical impact of routine follow-up coronary angiography (FUCAG) after percutaneous coronary intervention (PCI) in daily clinical practice in Japan. Background The long-term clinical impact of routine FUCAG after PCI in real-world clinical practice has not been evaluated adequately. Methods In this prospective, multicenter, open-label, randomized trial, patients who underwent successful PCI were randomly assigned to routine angiographic follow-up (AF) group, in which patients were to receive FUCAG at 8 to 12 months after PCI, or clinical follow-up alone (CF) group. The primary endpoint was defined as a composite of death, myocardial infarction, stroke, emergency hospitalization for acute coronary syndrome, or hospitalization for heart failure over a minimum of 1.5 years follow-up. Results Between May 2010 and July 2014, 700 patients were enrolled in the trial among 22 participating centers and were randomly assigned to the AF group (n = 349) or the CF group (n = 351). During a median of 4.6 years of follow-up (interquartile range [IQR]: 3.1 to 5.2 years), the cumulative 5-year incidence of the primary endpoint was 22.4% in the AF group and 24.7% in the CF group (hazard ratio: 0.94; 95% confidence interval: 0.67 to 1.31; p = 0.70). Any coronary revascularization within the first year was more frequently performed in AF group than in CF group (12.8% vs. 3.8%; log-rank p < 0.001), although the difference between the 2 groups attenuated over time with a similar cumulative 5-year incidence (19.6% vs. 18.1%; log-rank p = 0.92). Conclusions No clinical benefits were observed for routine FUCAG after PCI and early coronary revascularization rates were increased within routine FUCAG strategy in the current trial. (Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial [ReACT]; NCT01123291)

Original languageEnglish
Pages (from-to)109-117
Number of pages9
JournalJACC: Cardiovascular Interventions
Volume10
Issue number2
DOIs
Publication statusPublished - 2017 Jan 23
Externally publishedYes

Keywords

  • angiographic follow-up
  • percutaneous coronary intervention
  • prognosis
  • stent(s)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial'. Together they form a unique fingerprint.

Cite this